Predicting Future Bone Loss in Perimenopause: Tools for Better Identification
Bone turnover markers and Trabecular Bone Score might be useful tools to identify transmenopausal women who are at greater risk for bone loss.
Osteoporosis
No Association Between DPP-4 Inhibitor, GLP-1 Receptor Agonist, SGLT2 Inhibitor Use and Fracture Risk
Researchers found no association between the use of DPP-4 inhibitors, GLP-1 receptor agonists, or SGLT2 inhibitors and the risk for fracture in patients with type 2 diabetes.
Long-Term Denosumab Treatment Reduces Nonvertebral Fractures in Osteoporosis
Compared with the first 3 years of denosumab treatment, a longer duration of denosumab therapy was associated with further decrease in nonvertebral fracture rate, which was sustained through 10 years of treatment.
Gender-Affirming Hormone Treatment Does Not Negatively Affect Bone Health
Gender-affirming hormone treatment may lead to changes in bone turnover markers in transgender men and women, but overall does not have negative effects on bone health.
Osteopenia Rates in Early Middle Age Indicate Increased Osteoporosis Screening Needs
Osteopenia was found in more than 25% of both men and women, suggesting that more osteoporosis screening and prevention programs are needed in middle-age individuals.
Cause or Effect? The Link Between Psychological Stress and Osteoporosis
An osteoporosis diagnosis may affect a patient’s mental health because of diminished quality of life, fear of falling, embarrassment about posture changes, or general depression about the diagnosis.
Osteoporosis Linked to Lower Quality of Life Regardless of Fracture History
Even without a history of fragility fracture, the presence of osteoporosis is associated with substantially lower health-related quality of life.
Parity, Lactation, and Fracture Risk: What’s the Link?
Parity and lactation had a neutral effect on the risk for fragility fractures or radiographic vertebral compression fractures over 10 years of follow-up.
Increased Risk for Osteoporosis, Osteoarthritis in Patients With Cerebral Palsy
Researchers used epidemiologic evidence to better understand the risk for osteoporosis and osteoarthritis in patients with cerebral palsy.
FRAX Risk Tool Useful for Women Receiving Aromatase Inhibitor Therapy
The FRAX fracture risk tool can stratify fracture risk equally well among women receiving aromatase inhibitor (AI) therapy for breast cancer and nonusers of AI therapy.
Next post in News
